Product Overview
[Drug Name]
Generic Name: Bismuth Potassium Citrate Tablets
Trade Name: Lizhu Dele Bismuth Potassium Citrate Tablets 0.3g*24 Tablets
Pinyin Code: LiZhuDeLe ZuoZuoSuanZuoJiaPian 0.3g*24 Tablets
[Main Ingredient]
Bismuth Tripotassium Dicitrate. Chemical Name: Bismuth Tripotassium Dicitrate. Molecular Formula: C12H10BiK3014. Molecular Weight: 704.47
[Properties]
This product consists of white granules.
[Indications/Main Functions]
This product is used for chronic gastritis and to relieve stomach pain, burning sensation, and acid reflux caused by excessive gastric acid.
[Specifications]
0.3g*24 tablets
[Dosage and Administration]
Oral. Take 0.3g (1 tablet) four times daily. The first three doses should be taken half an hour before meals and the fourth dose should be taken two hours after dinner. Alternatively, take 0.6g (2 tablets) twice daily, morning and evening. A course of treatment consists of 28 consecutive days. If continued, follow your doctor's advice.
[Adverse Reactions]
During medication, an ammonia odor may be present in the mouth, and the tongue coating and stool may turn grayish-black. This will disappear upon discontinuation of medication. Nausea and constipation may occur occasionally.
[Contraindications]
This product is contraindicated in patients with allergies to any component, severe liver or kidney impairment, or pregnant or lactating women.
[Drug Interactions]
1. Milk and antacids may interfere with the effects of this product and should not be taken concurrently.
2. Taking this product concurrently with tetracycline may affect its absorption.
3. Concomitant use with other medications may result in drug interactions. Please consult your doctor or pharmacist for details.
[Precautions]
1. Please take the medication correctly as recommended during treatment.
2. Gray-black stools are caused by the metabolism of bismuth in the potassium citrate capsules in this product to form bismuth sulfide. This condition will resolve spontaneously after discontinuation of the medication.
3. Bismuth potassium citrate capsules in this product should not be taken with milk, alcohol, or carbonated beverages to avoid affecting the efficacy.
4. Taking tinidazole tablets in this product with alcoholic beverages may cause abdominal cramps, facial flushing, or vomiting.
5. Clarithromycin tablets in this product are primarily metabolized and excreted in the liver. Use with caution in patients with hepatic insufficiency or severe renal impairment.
6. Clarithromycin tablets in this product can interfere with the blood concentration of carbamazepine, potentially increasing its effect. For patients taking both drugs together, the carbamazepine dosage should be adjusted accordingly.
7. Macrolide antibiotics have been reported to alter the metabolism of terfenadine, increasing its concentration and occasionally causing arrhythmias.
[Pediatric Use]
1. Consult your physician or pharmacist regarding dosage for children. 2. Keep out of reach of children.
3. Children must use this product under adult supervision.
[Use in Elderly Patients]
The tolerance of elderly patients is similar to that of younger patients.
[Overdose]
See package insert.
[Pharmacology and Toxicology]
This product is a gastric mucosal protective agent. Under acidic conditions, it forms a diffuse protective layer covering the ulcer surface, preventing the invasion of gastric acid, enzymes, and food, promoting mucosal regeneration and healing. It also protects the gastric mucosa by reducing pepsin activity, increasing mucin secretion, and promoting the release of progesterone (PGE2) from the mucosa. Furthermore, it has a killing effect on Helicobacter pylori (Hp), thereby promoting the healing of gastritis.
